✦ LIBER ✦

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

✍ Scribed by Ott, Patrick A.; Carvajal, Richard D.; Pandit-Taskar, Neeta; Jungbluth, Achim A.; Hoffman, Eric W.; Wu, Bor-Wen; Bomalaski, John S.; Venhaus, Ralph; Pan, Linda; Old, Lloyd J.; Pavlick, Anna C.; Wolchok, Jedd D.

Book ID: 111985161
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 490 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9862-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised phase II study of pegylated

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

✍ Yang, T-S; Lu, S-N; Chao, Y; Sheen, I-S; Lin, C-C; Wang, T-E; Chen, S-C; Wang, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 431 KB

221 A randomized phase II trial of pegyl

221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma

✍ Szlosarek, P.W.; Fennell, D.A.; Rudd, R.M.; Lind, M.; Ranson, M.; Hackshaw, A.; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Phase I/II Study of the Antibody-Drug Co

Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

✍ Ott, P. A.; Hamid, O.; Pavlick, A. C.; Kluger, H.; Kim, K. B.; Boasberg, P. D.; 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 254 KB

Phase I study of pegylated liposomal dox

Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies

✍ Paula M. Fracasso; Kristie A. Blum; Benjamin R. Tan; Carole L. Fears; Nancy L. B 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## Abstract ## BACKGROUND Pegylated liposomal doxorubicin (PEG‐LD) and gemcitabine have single‐agent activity in breast and ovarian carcinoma patients. We conducted a Phase I trial to evaluate the maximum tolerated dose (MTD) and toxicities of this combination in patients with advanced malignancie

Phase II study of weekly Kahalalide F in

Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma

✍ Salvador Martín-Algarra; Enrique Espinosa; Jordi Rubió; Juan José López López; J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A phase II and pharmacokinetic study of

A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

✍ Ruey-Long Hong; Yun-Long Tseng 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 200 KB